Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. C Type Natriuretic Peptide
2. C Type Natriuretic Peptide 22
3. C Type Natriuretic Peptide 53
4. C-type Natriuretic Peptide
5. C-type Natriuretic Peptide-22
6. C-type Natriuretic Peptide-53
7. Cnp-22
8. Cnp-53
9. Natriuretic Peptide, C Type
10. Natriuretic Peptide-22, C-type
11. Natriuretic Peptide-53, C-type
12. Peptide, C-type Natriuretic
13. Peptide-22, C-type Natriuretic
14. Peptide-53, C-type Natriuretic
1. 127869-51-6
2. C-type Natriuretic Peptide (32-53) (human, Porcine, Rat)
3. C-type Natriuretic Peptide (cnp) (1-22), Human
4. Atriopeptin C (pig)
5. Natriuretic Peptide,c-type
6. Cnp (1-22), Human
7. Unii-3vcd78874l
8. Cnp-53
9. Dtxsid60155686
10. 3vcd78874l
11. Bdbm287915
12. Us10087144, Compound Cnp
13. Akos024457659
14. Natriuretic Peptide, C-type, >=95% (hplc)
15. C-type Natriuretic Peptide (1-22) (human, Rat, Swine)
16. C-type Natriuretic Peptide (32-53) (human, Porcine, Rat) Acetate Salt
17. Natriuretic Peptide, C-type, Human And Porcine - Cas 127869-51-6
18. C-type Natriuretic Peptide (cnp) (1-22), Humanc-type Natriuretic Peptide (cnp) (1-22), Human
19. H-gly-leu-ser-lys-gly-cys-phe-gly-leu-lys-leu-asp-arg-ile-gly-ser-met-ser-gly-leu-gly-cys-oh
| Molecular Weight | 2197.6 g/mol |
|---|---|
| Molecular Formula | C93H157N27O28S3 |
| XLogP3 | -8.7 |
| Hydrogen Bond Donor Count | 32 |
| Hydrogen Bond Acceptor Count | 35 |
| Rotatable Bond Count | 44 |
| Exact Mass | 2196.0853510 g/mol |
| Monoisotopic Mass | 2196.0853510 g/mol |
| Topological Polar Surface Area | 962 Ų |
| Heavy Atom Count | 151 |
| Formal Charge | 0 |
| Complexity | 4490 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 17 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
Natriuretic Agents
Endogenous or exogenous chemicals that regulate the WATER-ELECTROLYTE BALANCE in the body. They consist of peptides and non-peptide compounds. (See all compounds classified as Natriuretic Agents.)
Drugs in Development
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Digital Content
NEWS #PharmaBuzz
ABOUT THIS PAGE
A Natriuretic Peptide, C-Type manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Natriuretic Peptide, C-Type, including repackagers and relabelers. The FDA regulates Natriuretic Peptide, C-Type manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Natriuretic Peptide, C-Type API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Natriuretic Peptide, C-Type supplier is an individual or a company that provides Natriuretic Peptide, C-Type active pharmaceutical ingredient (API) or Natriuretic Peptide, C-Type finished formulations upon request. The Natriuretic Peptide, C-Type suppliers may include Natriuretic Peptide, C-Type API manufacturers, exporters, distributors and traders.
Natriuretic Peptide, C-Type Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Natriuretic Peptide, C-Type GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Natriuretic Peptide, C-Type GMP manufacturer or Natriuretic Peptide, C-Type GMP API supplier for your needs.
A Natriuretic Peptide, C-Type CoA (Certificate of Analysis) is a formal document that attests to Natriuretic Peptide, C-Type's compliance with Natriuretic Peptide, C-Type specifications and serves as a tool for batch-level quality control.
Natriuretic Peptide, C-Type CoA mostly includes findings from lab analyses of a specific batch. For each Natriuretic Peptide, C-Type CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Natriuretic Peptide, C-Type may be tested according to a variety of international standards, such as European Pharmacopoeia (Natriuretic Peptide, C-Type EP), Natriuretic Peptide, C-Type JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Natriuretic Peptide, C-Type USP).
LOOKING FOR A SUPPLIER?
